Overall rank by patents
#10,888
Across all tracked assignees
USPTO PatentsView assignee record - 28 granted patents across 11 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
CLPH holds 28 US patents across 11 technology areas, rank #10,888 of 50,000 tracked assignees.
CLPH, Llc has been granted 28 US utility patents between 2016 and 2025, placing CLPH, Llc at rank #10,888 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.4 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, CLPH, Llc is one of the more focused assignees in the PatentsView dataset. By volume, CLPH sits between Canon Nanotechnologies, Inc. (28 patents, rank #10,884) and Crucialtec Co. Ltd (28 patents, rank #10,892) - the closest US assignees by grant volume. The composite Innovation Score of 40.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 13 grants, compared with 15 in the 2015–2019 window, a -13% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. CLPH, Llc's 20.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CLPH, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CANON NANOTECHNOLOGIES, INC.
28 patents
CARBIOS
28 patents
CEDES AG
28 patents
CELANESE SALES GERMANY GMBH
28 patents
COMET AG
28 patents
CONTECH ENGINEERED SOLUTIONS LLC
28 patents
CROCUS TECHNOLOGY INC.
28 patents
CRUCIALTEC CO. LTD
28 patents
CLPH, LLC
28 patents
What this shows CLPH holds 28 patents at rank #10,888, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,888 in granted patent volume.
Other assignees with the most granted patents in CLPH's primary technology class.
CLPH's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 7.1% |
| 2017 | 3 | 10.7% |
| 2018 | 5 | 17.9% |
| 2019 | 5 | 17.9% |
| 2020 | 2 | 7.1% |
| 2021 | 2 | 7.1% |
| 2022 | 4 | 14.3% |
| 2023 | 1 | 3.6% |
| 2024 | 1 | 3.6% |
| 2025 | 3 | 10.7% |
Top 11 of 11 technology areas
Overall rank by patents
#10,888
Across all tracked assignees
40.0 out of 100
How to use this portfolio
CLPH's 28 grants land it in the top 37% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.